-
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| Industry | Biotechnology |
| ISIN | PLPRBLG00010 |
| Sector | Healthcare |
| Market Cap | 34M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.47 |
| Dividend Yield | None |
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFß1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the aVß8 integrin. The company was founded in 2010 and is based in Wroclaw, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PUR.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026